Pitalip

Pitalip

pitavastatin

Manufacturer:

Daewoong Pharmaceutical

Distributor:

Zuellig Pharma

Marketer:

Abbott
Concise Prescribing Info
Contents
Pitavastatin Ca
Indications/Uses
Hypercholesterolemia, familial hypercholesterolemia.
Dosage/Direction for Use
Adult 1-2 mg once daily. Max: 4 mg/day.
Administration
Should be taken with food: Take after the evening meal.
Contraindications
Hypersensitivity. Active liver disease, including unexplained, persistent elevations in serum aminotransferase (transaminase) conc. Concomitant use w/ cyclosporine. Pregnancy & lactation.
Special Precautions
Severe renal impairment (GFR <30 mL/min). Perform liver function test prior to initiation of therapy & periodically thereafter. Reduce or discontinue if increases in AST or ALT conc exceeds 3x ULN ranges. Alcoholics. Advanced age, renal impairment, hypothyroidism & concomitant use of particular antilipemic agents (ie, fibric acid derivatives & niacin) are predisposing factors of myopathy & rhabdomyolysis. Discontinue if serum creatine kinase level increases.
Adverse Reactions
Arthralgia, headache, influenza, nasopharyngitis, allergy/hypersensitivity, increase in serum CK, aminotransferase, alkaline phosphatase, bilirubin & glucose.
Drug Interactions
Increased Cmax & AUC w/ cyclosporine & erythromycin. Augmented risk of musculoskeletal effects & laboratory abnormalities w/ fibric acid derivatives (fenofibrate, gemfibrozil). Possible increased risk of musculoskeletal effects w/ niacin. Increased exposure w/ rifampin.
ATC Classification
C10AA08 - pitavastatin ; Belongs to the class of HMG CoA reductase inhibitors. Used in the treatment of hyperlipidemia.
Presentation/Packing
Form
Pitalip FC tab 2 mg
Packing/Price
10 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in